Twitter Facebook-f Youtube Instagram Linkedin
NETs Info
Donate
Close Menu
  • Who We Are
    • About Us
    • Our People
    • Our Board
    • Our Ambassadors
    • Consumer Advisory Group
    • Research Advisory Panel
    • Governance & Policy
  • Neuroendocrine Cancers
    • What are Neuroendocrine Cancers?
    • Patient Resources
    • Pheos and Paras
    • NET Library
  • I Am a Patient
    • Patient Support
    • Patient Resources
    • NET Nurse
    • Patient Stories
    • Australian NET Specialists
    • Current Clinical Trials
  • I am a HCP
    • Professional Learning
    • HCP – Patient Referral to NET Nurse
    • Current Clinical Trials
    • NET Library
    • HCP Newsletter & Signup
    • Australian NET Specialists
    • Request an In-Service
    • PLANET Registry
    • Order booklets and other resources
  • Get Involved
    • NET National Action Plan
    • Share your story
    • Donate
    • Fundraise
    • In Memoriam
    • Corporate Partners
    • Bequests
    • Workplace Giving
    • Volunteer
  • What’s On
    • News
    • Newsletter & Signup
    • INCA Newsletter archive
    • Events
  • Shop
  • Contact Us
Donate
  • Who We Are
    • About Us
    • Our People
    • Our Board
    • Our Ambassadors
    • Consumer Advisory Group
    • Research Advisory Panel
    • Governance & Policy
  • Neuroendocrine Cancers
    • What are Neuroendocrine Cancers?
    • Patient Resources
    • Pheos and Paras
    • NET Library
  • I Am a Patient
    • Patient Support
    • Patient Resources
    • NET Nurse
    • Patient Stories
    • Australian NET Specialists
    • Current Clinical Trials
  • I am a HCP
    • Professional Learning
    • HCP – Patient Referral to NET Nurse
    • Current Clinical Trials
    • NET Library
    • HCP Newsletter & Signup
    • Australian NET Specialists
    • Request an In-Service
    • PLANET Registry
    • Order booklets and other resources
  • Get Involved
    • NET National Action Plan
    • Share your story
    • Donate
    • Fundraise
    • In Memoriam
    • Corporate Partners
    • Bequests
    • Workplace Giving
    • Volunteer
  • What’s On
    • News
    • Newsletter & Signup
    • INCA Newsletter archive
    • Events
  • Shop
  • Contact Us

Home » Advocacy » Survivorship Conference Feb 2018

Survivorship Conference Feb 2018

  • March 7, 2018

 

Unicorn Foundation NET Nurse Kate Wakelin attended the 2nd Victorian Cancer Survivorship Conference in February 2018.  Read Kate's reflections on this informative event below….

Earlier in February I had the opportunity to attend the 2nd
Victorian Cancer Survivorship Conference at The Walter and Eliza Hall Institute
in Melbourne.

This was preceded by a day of networking with other not-for-profit
organisations who provide services to cancer survivors. This day was a
brilliant opportunity to showcase services, explore common issues and identify
opportunities for collaboration. Many valuable connections were also made over
this time.

The conference itself provided a fast-paced series of
presentations over the two days, with a diverse range of national and
international speakers. One of the things that was particularly encouraging was
discussion around how the term “survivorship” has evolved particularly in terms
of its approach to people who are having ongoing management for metastatic
cancers and those who are living with their illness as a chronic condition –
something obviously very relevant to people affected by NETs.

One of the major areas of focus was in the use of
survivorship care plans (SCPs). This was very timely for us as an organisation,
as we have been collaborating with the Australian Cancer Survivorship Centre in
developing a NET specific SCP, so it will be very useful to draw on this
current research as we move ahead with this project.

It was also fantastic to see NETs represented, both in the
oral presentations, with Dr David Wyld (QLD) providing great insights in his
presentation: “How the rare see their care: perceptions of care and patient reported outcomes in people living with
neuroendocrine tumours. Exploration of perceptions of care and patient reported
outcomes for people with NETs”, and Dr Gabrielle Cehic presenting some of the
current impressive international collaborative work that is being done in her
poster: “The challenges of designing and implementing a structured,
international multicentre audit on health-related quality of life (HRQOL) and
markers of response in patients with neuroendocrine neoplasms (NEN) treated
with peptide receptor radionuclide therapy (PRRT)”.

As always, the official content of these events is only part
of the equation, with much of the value being in the interactions that take
place during the informal program. It was fantastic to catch up with colleagues
I already knew, as well as to meet new faces and explore ideas and approaches
to challenges. I emerged feeling inspired and energised, looking forward to
continuing the work the Unicorn Foundation are doing in this space.

     

 

 

Share this post

Subscribe to our eNews

Stay up to date on news and events, clinical trials and new research on neuroendocrine cancers.

Recent posts

5HIAA Urine Collection Instructions for Patients

June 23, 2022

Donor Report 2021/2022

June 21, 2022

Cancer Nurses Society of Australia 24th Annual Congress

June 18, 2022

The Future of Precision Oncology in Nuclear Medicine – Report

June 16, 2022
Categories
  • Advocacy
  • Awareness
  • Community Events
  • Education
  • Events
  • Fundraising
  • General
  • In The Media
  • News
  • Research
  • Unicorn Events
PrevPreviousUnicorn Foundation presenting at ENETS
NextENETS wrap up from CAG member Katie GoldenNext

Related Posts

5HIAA Urine Collection Instructions for Patients

Your doctor may order you to do a 5HIAA 24 hour urine test. Please click below to see the downloadable instruction sheet. Previously there were

Donor Report 2021/2022

It is with heartfelt gratitude that we thank our kind donors who enable us to continue to do what we do. We encourage you to

Cancer Nurses Society of Australia 24th Annual Congress

The 24th Cancer Nurses Society of Australia’s  (CNSA) Annual Congress took place at Brisbane Convention Centre Thursday 16 June to Saturday 18 June 2022. The

The Future of Precision Oncology in Nuclear Medicine – Report

Theranostics refers to a combined therapy and diagnostics approach to patient treatment. It involves the use of a diagnostic drug to first identify and label

View All

Make a difference

How much do you wish to donate?
$50
$100
$250
$500
$1000
Other
NeuroEndocrine Cancer Australia logo white
Twitter Facebook-f Youtube Instagram Linkedin

All donations are tax deductible.
Registered Charity CFN 202607

Who We Are

  • About Us
  • Our People
  • Our Ambassadors
  • Consumer Advisory Group
  • Research Advisory Panel
  • Governance & Policies
Menu
  • About Us
  • Our People
  • Our Ambassadors
  • Consumer Advisory Group
  • Research Advisory Panel
  • Governance & Policies

Neuroendocrine Cancers

  • What are Neuroendocrine Cancers?​
  • Pheos and Paras
  • NET Library
Menu
  • What are Neuroendocrine Cancers?​
  • Pheos and Paras
  • NET Library

For Patients

  • Patient resources
  • NET Nurse
  • Patient Stories
  • Australian NET Specialists
  • Current Open Clinical Trials
Menu
  • Patient resources
  • NET Nurse
  • Patient Stories
  • Australian NET Specialists
  • Current Open Clinical Trials

Get Involved

  • Shop
  • Donate
  • Volunteer
  • Current Fundraising Campaigns
  • Fundraise
Menu
  • Shop
  • Donate
  • Volunteer
  • Current Fundraising Campaigns
  • Fundraise

© 2020 NeuroEndocrine Cancer Australia

  • Website by Five Creative